48
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Relevance of genetic polymorphisms in inflammatory response to percutaneous coronary intervention

, &
Pages 736-740 | Received 02 Feb 2009, Accepted 15 May 2009, Published online: 25 Nov 2009

References

  • Azar RR, McKay RG, Kieman FJ, Seecharran B, Feng YJ, Fram DB, Wu AH, Waters DD, . Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol. 1997; 80:1476–8.
  • Saleh N, Tornvall P, . Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis. 2007; 195:374–8.
  • Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, Ghini AS, Ferrero V, Chiariello L, Gioffre PA, Romeo F, Crea F, . Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation. J Am Coll Cardiol. 2002; 40:1935–42.
  • Ozdol C, Gulec S, Rahimov U, Atmaca Y, Turhan S, Erol C, . Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention. Thromb Res. 2007; 119:453–9.
  • Saleh N, Svane B, Hansson L-O, Jensen J, Nilsson T, Danielsson O, Tornvall P, . Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem. 2005; 51:2124–30.
  • Saleh N, Svane B, Jensen J, Hansson L-O, Nordin M, Tornvall P, . Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and Interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J. 2005; 149:876–82.
  • Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, Liu K, Williams OD, Iribarren C, Lewis EC, Fomage M, Boerwinkle E, Gross M, Jaquish C, Nickerson DA, Myers RM, Siscowick DS, Reiner AP, . Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005; 77:64–77.
  • Kovacs A, Green F, Hansson L-O, Lundman P, Samnegård A, Boquist S, Ericsson C-G, Watkins H, Hamsten A, Tornvall P, . A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with plasma concentrations of C-reactive protein. Atherosclerosis. 2005; 178:193–8.
  • Terry CF, Loukaci V, Green FR, . Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000; 275:18138–44.
  • Bennermo M, Held C, Stemme S, Ericsson C-G, Silveira A, Green F, Tornvall P, . Genetic predisposition to the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin Chem. 2004; 50:2136–40.
  • Ronaghi M, Uhlén M, Nyrén P, . DNA sequencing: a sequencing method based on real-time pyrophosphate. Science. 1998; 281:363–5.
  • Zee RYL, Hegener HH, Fernandez-Cruz A, Lindpaintner K, . C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis. Atherosclerosis. 2004; 176:393–6.
  • Marso SP, House JA, Hopkins PJ, . Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G>C polymorphism and complex plaque morphology. Int J Immunogenetics. 2006; 33:347–54.
  • Merino A, Gaya A, Segura I, Calvo J, Imizcoz C, Berenguel A, Alegria E, . Platelet aggregation inhibition blocks C-reactive protein and interleukin-6 (IL-6) elevation after the coronary angioplasty: effects of the -174G>C IL-6 gene polymorphism. Am J Cardiol. 2004; 94:1300–3.
  • Danik JK, Ridker PM, . Genetic determinants of C-reactive protein. Curr Atheroscler Rep. 2007; 9:195–203.
  • Brull DJ, Serrano N, Zito F, Jonas L, Montgomery HE, Rumley A, Sharma P, Lowe GD, World MJ, Humphries SE, Hingorani AD, . Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003; 23:2063–9.
  • D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS, . C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis. 2005; 179:413–7.
  • Bennermo M, Held C, Watkins H, Green F, Hamsten A, Strandberg L-E, Ericsson C-G, Hansson L-O, Tornvall P, . Prognostic value of the interleukin-6 gene -174 G>C and -572 G>C promoter polymorphism and plasma interleukin-6 levels in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis. 2004; 174:157–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.